CIM Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,721
| Closed | -$203K | – | 285 |
|
|
2021
Q4 | $203K | Buy |
+1,721
| New | +$203K | 0.06% | 289 |
|
|
2019
Q2 | – | Sell |
-21,546
| Closed | -$368K | – | 336 |
|
|
2019
Q1 | $368K | Sell |
21,546
-183
| -0.8% | -$3.13K | 0.14% | 191 |
|
|
2018
Q4 | $297K | Hold |
21,729
| – | – | 0.13% | 210 |
|
|
2018
Q3 | $622K | Hold |
21,729
| – | – | 0.22% | 101 |
|
|
2018
Q2 | $595K | Hold |
21,729
| – | – | 0.21% | 126 |
|
|
2018
Q1 | $458K | Buy |
+21,729
| New | +$458K | 0.16% | 186 |
|